Bliss GVS Pharma Limited (BLISSGVS) — Board Meeting

1 Board Meeting 🟡 Notable Neutral 📄 PDF

No summary available

2 Board Meeting 🟡 Notable Neutral 📄 PDF

📢 Key Event
Board approves leadership changes effective July 2026

🔄 What Changed
New CEO appointment and CFO transition; director appointment

🔮 What's Next
July 15, 2026 start date for new CEO

💡 Investor Takeaway
Leadership reshuffle signals strategic continuity with new CEO focus on growth while preserving existing management structure.

Bliss GVS Pharma announced board approval of three key leadership changes effective July 2026: appointment of Santosh Parab as Additional Director, Rahul Adakmol as new CEO starting July 15, and Narsimha Kamath stepping down as CEO while remaining Managing Director. The appointments follow regulatory requirements and were formalized through video conference.

3 Board Meeting 🟡 Notable Neutral 📄 PDF

📢 Key Event
Board approves new director, CEO succession, and CEO resignation

🔄 What Changed
Added Non-Executive Director Santosh Parab; appointed Rahul Adakmol as CEO; Narsimha Kamath stepped down as CEO but remains Managing Director

🔮 What's Next
July 15, 2026 start date for Rahul Adakmol as CEO

💡 Investor Takeaway
Leadership reshuffle with new CEO and director appointments effective mid-2026

Bliss GVS Pharma announced board approval of three key changes: appointment of Santosh Parab as Additional Director effective July 3, 2026; appointment of Rahul Adakmol as CEO effective July 15, 2026; and resignation of Narsimha Kamath from CEO role effective close of business July 14, 2026, while retaining his Managing Director position.

4 Board Meeting 🟡 Notable Neutral 📄 PDF

📢 Key Event
Board approves new director and CEO appointments, CEO resignation

🔄 What Changed
Appointed Santosh Parab as additional director; appointed Rahul Adakmol as CEO; Narsimha Kamath resigned as CEO

💡 Investor Takeaway
Leadership changes may affect strategic direction and execution capabilities.

The board approved the appointment of Santosh Parab as an additional non-executive director effective July 3, 2026, and Rahul Adakmol as CEO effective July 15, 2026, while Narsimha Kamath resigned as CEO effective close of business July 14, 2026, continuing as Managing Director. The changes reflect leadership succession and governance updates.

📊 Stock Analysis — BLISSGVS ✨ Ask AI About This